Shares of ANGLE plc (LON:AGL – Get Free Report) were up 16.4% during mid-day trading on Friday . The stock traded as high as GBX 16.95 ($0.21) and last traded at GBX 16 ($0.20). Approximately 2,657,326 shares traded hands during mid-day trading, a decline of 14% from the average daily volume of 3,074,922 shares. The stock had previously closed at GBX 13.75 ($0.17).
Wall Street Analysts Forecast Growth
Separately, Berenberg Bank reaffirmed a “buy” rating and set a GBX 70 ($0.88) price objective on shares of ANGLE in a research note on Wednesday, April 24th.
ANGLE Trading Up 29.1 %
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
Read More
- Five stocks we like better than ANGLE
- The Role Economic Reports Play in a Successful Investment Strategy
- MarketBeat Week in Review – 4/29 – 5/3
- What Does Downgrade Mean in Investing?
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- How to Choose Top Rated Stocks
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.